Search Tag: Hologic

2015 06 Apr

BEDFORD, Mass. , / PRNewswire / -- Hologic, Inc. (NASDAQ: HOLX) announced that the Company plans to release its operating results for the second quarter of fiscal 2015 on  Wednesday, April 29, 2015 , after the market closes.  In conjunction with the release, management will host a conference call that day at  4:30 p.m. Eastern Time . Interested participants...Read more

2015 01 Apr

BEDFORD, Mass. ,/ PRNewswire / -- Hologic, Inc. (NASDAQ: HOLX) announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued  November 23, 2010 , and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. ...Read more

2015 26 Feb

The amount of clinical proof for the efficacy of Tomosynthesis in screening is significantly larger than the proof available in the early days of the transition from analog mammography to FFDM.  Results from studies in Europe using Tomosynthesis in population based screening and results from screening with Tomosynthesis in the USA are concordant...Read more

2014 12 Feb

Research supports the use of Hologic's lower dose 3D mammography technology and the continued use of two-views over one in breast cancer screening Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women,...Read more

2014 28 Jan

With an emphasis on improving lives, Hologic is focused on bringing the latest in diagnostic innovations to the fast growing Gulf region Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, will feature...Read more

2013 22 Nov

3D Mammography, Hologic's game-changing breast cancer screening technology, is a major focus at the largest radiology gathering in the world Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women,...Read more

2013 17 Sep

Growing number of peer-reviewed clinical publications document significant advantages of  H ologic® tomosynthesis; Now, Hologic has further advanced tomosynthesis with faster and  lower-dose options including the C-View™ software option for 2D imaging and the Affirm™  tomosynthesis biopsy procedure. Tomosynthesis is going from strength...Read more

2013 24 May

Hologic has announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic's 3D mammography technology (breast tomosynthesis) with conventional 2D mammography alone showed a significant reduction in recall rates and a sizeable increase in cancer detection, particularly invasive cancer,...Read more

2013 24 May

Hologic has announced US Food and Drug Administration approval of its new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography (breast tomosynthesis) screening exam. C-View images are generated from the 3D tomosynthesis data acquired during...Read more

2013 17 May

Hologic  has announced its results for the second fiscal quarter ended March 30, 2013. Highlights Include: Financial: Revenues of $612.7 million, net of a $(6.4) million adjustment related to contingent revenue earned and received under Gen‐Probe Incorporated's (Gen‐Probe) collaboration agreement with Novartis. Non‐GAAP adjusted revenues...Read more

2013 09 May

Hologic has announced the publication of the final results of a large-scale prospective study comparing breast cancer screening using Hologic's 2D mammography plus tomosynthesis (Breast Tomosynthesis) with conventional 2D mammography published online in advance of print by The Lancet Oncology. The study, "Integration of 3D digital mammography with...Read more

2013 21 Mar

Breast tomosynthesis has created a lot of interest within the women’s imaging community. While the clinical benefits are becoming more apparent, the reimbursements in the U.S. are inconsistent, and it is expensive to adopt this technology. Providers want to know: Is it worth the investment? Is a positive return on investment (ROI) possible? Hologic...Read more